NCT01294553 An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010 Status COMPLETED Phase N/A
NCT01292213 A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom Status TERMINATED Phase N/A
NCT01290601 Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults Status TERMINATED Phase PHASE2
NCT01290393 Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada Status TERMINATED Phase N/A
NCT01290354 Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer Status COMPLETED Phase PHASE1
NCT01289418 Surveillance for Adverse Events Following Pandemic H1N1 Immunization Status COMPLETED Phase N/A
NCT01287065 A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function Status COMPLETED Phase PHASE2
NCT01286831 A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444. Status COMPLETED Phase PHASE1
NCT01286285 Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria Status UNKNOWN Phase N/A
NCT01286038 Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia Status TERMINATED Phase PHASE1
NCT01283789 Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT01283100 A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects. Status WITHDRAWN Phase PHASE1
NCT01277705 Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® Status COMPLETED Phase PHASE3
NCT01277692 A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients. Status COMPLETED Phase PHASE1
NCT01277679 Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure Status COMPLETED Phase PHASE1
NCT01277666 A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT01277042 Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years) Status COMPLETED Phase PHASE3